- Home
- RLGT vs TNGX Comparison
RLGT vs TNGX Comparison
Compare RLGT & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- TNGX
- Stock Information
- Founded
- RLGT 2001
- TNGX 2014
- Country
- RLGT United States
- TNGX United States
- Employees
- RLGT N/A
- TNGX N/A
- Industry
- RLGT Oil Refining/Marketing
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- RLGT Consumer Discretionary
- TNGX Health Care
- Exchange
- RLGT Nasdaq
- TNGX Nasdaq
- Market Cap
- RLGT 317.8M
- TNGX 317.4M
- IPO Year
- RLGT N/A
- TNGX N/A
- Fundamental
- Price
- RLGT $6.31
- TNGX $1.73
- Analyst Decision
- RLGT
- TNGX Strong Buy
- Analyst Count
- RLGT 0
- TNGX 7
- Target Price
- RLGT N/A
- TNGX $12.33
- AVG Volume (30 Days)
- RLGT 135.7K
- TNGX 801.9K
- Earning Date
- RLGT 05-08-2025
- TNGX 05-07-2025
- Dividend Yield
- RLGT N/A
- TNGX N/A
- EPS Growth
- RLGT 32.26
- TNGX N/A
- EPS
- RLGT 0.29
- TNGX N/A
- Revenue
- RLGT $858,699,000.00
- TNGX $42,069,000.00
- Revenue This Year
- RLGT $12.86
- TNGX N/A
- Revenue Next Year
- RLGT $5.75
- TNGX N/A
- P/E Ratio
- RLGT $21.72
- TNGX N/A
- Revenue Growth
- RLGT N/A
- TNGX 15.17
- 52 Week Low
- RLGT $4.83
- TNGX $1.71
- 52 Week High
- RLGT $7.94
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- RLGT 37.91
- TNGX 31.59
- Support Level
- RLGT $6.19
- TNGX $1.80
- Resistance Level
- RLGT $6.43
- TNGX $2.04
- Average True Range (ATR)
- RLGT 0.20
- TNGX 0.21
- MACD
- RLGT -0.03
- TNGX 0.01
- Stochastic Oscillator
- RLGT 17.91
- TNGX 3.94
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.